5.4 kb mouse ap2 promoter construct Search Results


93
Developmental Studies Hybridoma Bank alkaline phosphatase alp
Alkaline Phosphatase Alp, supplied by Developmental Studies Hybridoma Bank, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/alkaline phosphatase alp/product/Developmental Studies Hybridoma Bank
Average 93 stars, based on 1 article reviews
alkaline phosphatase alp - by Bioz Stars, 2026-06
93/100 stars
  Buy from Supplier

90
Promega pgl3-basic
Pgl3 Basic, supplied by Promega, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/pgl3-basic/product/Promega
Average 90 stars, based on 1 article reviews
pgl3-basic - by Bioz Stars, 2026-06
90/100 stars
  Buy from Supplier

alg5  (Abcam)
99
Abcam alg5
Primer sequences for specific genes.
Alg5, supplied by Abcam, used in various techniques. Bioz Stars score: 99/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/alg5/product/Abcam
Average 99 stars, based on 1 article reviews
alg5 - by Bioz Stars, 2026-06
99/100 stars
  Buy from Supplier

Image Search Results


Primer sequences for specific genes.

Journal: Experimental and Therapeutic Medicine

Article Title: miR-4262 regulates chondrocyte viability, apoptosis, autophagy by targeting SIRT1 and activating PI3K/AKT/mTOR signaling pathway in rats with osteoarthritis

doi: 10.3892/etm.2017.5444

Figure Lengend Snippet: Primer sequences for specific genes.

Article Snippet: Total 50 µg protein sample (per lane) was separated on SDS-PAGE gel, blotted onto PVDF membranes, and blocked in 5% non-fat milk for 1 h. The membranes were probed with mouse polyclonal antibodies to ULK1 (120 kDa; 1;1,000; ab128859; Abcam, Cambridge, UK), ALG5 (32 kDa; 1;1,000; ab108327; Abcam), Beclin-1 (52 kDa; 1;1,000; ab62557; Abcam), LC3II/LC3I (LC3-II, 17 kDa, LC3-II 19 kDa; 1;1,000; ab48394; Abcam), COL2A1 (142 kDa; 1;1,000; ab34712; Abcam), ACAN (250 kDa; 1;1,000; ab36861; Abcam), MMP-13 (54 kDa; 1;1,000; ab39012; Abcam), ADAMTS-5 (73 kDa; 1;1,000; ab41037; Abcam), SIRT1 (120 kDa; 1;1,000; ab110304; Abcam), phospho-PI3K (p-PI3K) (84 kDa; 1;1,000; ab182651; Abcam), PI3K (123 kDa; 1;1,000; ab151549; Abcam), p-AKT (65 kDa; 1;1,000; SAB4301414; Sigma-Aldrich; Merck KGaA), AKT (55 kDa; 1;1,000; SAB4500797; Sigma-Aldrich; Merck KGaA), p-mTOR (250 kDa; 1;1,000; ab137133; Abcam), mTOR (252 kDa; 1;2,000; ab2732; Abcam), and GAPDH (36 kDa; 1;2,000; ab8245; Abcam) overnight at 4°C, respectively.

Techniques: Sequencing

TNF-α treatment significantly decreases cell viability and autophagy, as well as increases apoptosis and the expression of miR-4262 in chondrocytes. (A) The cell viability in control and TNF-α groups at 0, 12, 24, 48 h using CCK-8; (B) The cell apoptosis in control and TNF-α groups at 0, 12, 24, 48 h using TUNEL staining; (C) The expression of autophagy-related proteins, including ULK1, ALG5, Beclin-1, LC3II/LC3I, in control, TNF-α, RAPA and TNF-α + E64d + pepstatin A groups using western blotting; (D) The level of miR-4262 in control and TNF-α groups at 0, 12, 24, 48 h using quantitative reverse transcription PCR. Three independent experiments were performed in each assay. *P<0.05, **P<0.01, and ***P<0.001 compared with the control group, #P<0.05 compared with the TNF-α group. TNF-α, tumor necrosis factor-α; RAPA, rapamycin; ULK1, uncoordinated 51-like kinase 1; ALG5, asparagine-linked glycosylation 5.

Journal: Experimental and Therapeutic Medicine

Article Title: miR-4262 regulates chondrocyte viability, apoptosis, autophagy by targeting SIRT1 and activating PI3K/AKT/mTOR signaling pathway in rats with osteoarthritis

doi: 10.3892/etm.2017.5444

Figure Lengend Snippet: TNF-α treatment significantly decreases cell viability and autophagy, as well as increases apoptosis and the expression of miR-4262 in chondrocytes. (A) The cell viability in control and TNF-α groups at 0, 12, 24, 48 h using CCK-8; (B) The cell apoptosis in control and TNF-α groups at 0, 12, 24, 48 h using TUNEL staining; (C) The expression of autophagy-related proteins, including ULK1, ALG5, Beclin-1, LC3II/LC3I, in control, TNF-α, RAPA and TNF-α + E64d + pepstatin A groups using western blotting; (D) The level of miR-4262 in control and TNF-α groups at 0, 12, 24, 48 h using quantitative reverse transcription PCR. Three independent experiments were performed in each assay. *P<0.05, **P<0.01, and ***P<0.001 compared with the control group, #P<0.05 compared with the TNF-α group. TNF-α, tumor necrosis factor-α; RAPA, rapamycin; ULK1, uncoordinated 51-like kinase 1; ALG5, asparagine-linked glycosylation 5.

Article Snippet: Total 50 µg protein sample (per lane) was separated on SDS-PAGE gel, blotted onto PVDF membranes, and blocked in 5% non-fat milk for 1 h. The membranes were probed with mouse polyclonal antibodies to ULK1 (120 kDa; 1;1,000; ab128859; Abcam, Cambridge, UK), ALG5 (32 kDa; 1;1,000; ab108327; Abcam), Beclin-1 (52 kDa; 1;1,000; ab62557; Abcam), LC3II/LC3I (LC3-II, 17 kDa, LC3-II 19 kDa; 1;1,000; ab48394; Abcam), COL2A1 (142 kDa; 1;1,000; ab34712; Abcam), ACAN (250 kDa; 1;1,000; ab36861; Abcam), MMP-13 (54 kDa; 1;1,000; ab39012; Abcam), ADAMTS-5 (73 kDa; 1;1,000; ab41037; Abcam), SIRT1 (120 kDa; 1;1,000; ab110304; Abcam), phospho-PI3K (p-PI3K) (84 kDa; 1;1,000; ab182651; Abcam), PI3K (123 kDa; 1;1,000; ab151549; Abcam), p-AKT (65 kDa; 1;1,000; SAB4301414; Sigma-Aldrich; Merck KGaA), AKT (55 kDa; 1;1,000; SAB4500797; Sigma-Aldrich; Merck KGaA), p-mTOR (250 kDa; 1;1,000; ab137133; Abcam), mTOR (252 kDa; 1;2,000; ab2732; Abcam), and GAPDH (36 kDa; 1;2,000; ab8245; Abcam) overnight at 4°C, respectively.

Techniques: Expressing, CCK-8 Assay, TUNEL Assay, Staining, Western Blot

Upregulated miR-4262 further decreases cell viability, autophagy, and matrix synthesis as well as increases apoptosis in TNF-α-treated chondrocytes. (A) The miR-4262 level in control, scramble (control of mimic), miR-4262 mimic, NC (control of inhibitor), and miR-4262 inhibitor groups by qPCR; (B) The cell viability in control, scramble, miR-4262 mimic, inhibitor NC, and miR-4262 inhibitor groups using CCK-8; (C) The cell apoptosis in control, scramble, miR-4262 mimic, inhibitor NC, and miR-4262 inhibitor groups using TUNEL staining; (D) The expression of autophagy-related proteins, including ULK1, ALG5, Beclin-1, LC3II/LC3I, in control, scramble, miR-4262 mimic, inhibitor NC, and miR-4262 inhibitor groups using western blotting; (E) The cell viability in control, TNF-α, TNF-α + scramble, TNF-α + miR-4262 mimic, TNF-α + NC, and TNF-α + miR-4262 inhibitor groups using CCK-8; (F) The cell apoptosis in control, TNF-α, TNF-α + scramble, TNF-α + miR-4262 mimic, TNF-α + NC, and TNF-α + miR-4262 inhibitor groups using TUNEL staining; (G) The expression of autophagy-related proteins, including ULK1, ALG5, Beclin-1, LC3II/LC3I, in control, TNF-α, TNF-α+E64d+pepstatin (A) TNF-α + scramble, TNF-α + miR-4262 mimic, TNF-α + NC, and TNF-α + miR-4262 inhibitor groups using western blotting; (H) The expression of matrix synthesis-related proteins, such as COL2A1, ACAN, MMP-13 and ADAMTS-5, in control, TNF-α, TNF-α + scramble, TNF-α + miR-4262 mimic, TNF-α + NC, and TNF-α + miR-4262 inhibitor groups using western blotting. Three independent experiments were performed in each assay. *P<0.05, **P<0.01, and ***P<0.001 TNF-α, tumor necrosis factor-α; ULK1, uncoordinated 51-like kinase 1; ALG5, asparagine-linked glycosylation 5; COL2A1, type II collagen; ACAN, aggrecan; MMP-13, matrix metallo protease 13; ADAMTS-5, a disintegrin and metalloproteinase with thrombospondin motifs-5.

Journal: Experimental and Therapeutic Medicine

Article Title: miR-4262 regulates chondrocyte viability, apoptosis, autophagy by targeting SIRT1 and activating PI3K/AKT/mTOR signaling pathway in rats with osteoarthritis

doi: 10.3892/etm.2017.5444

Figure Lengend Snippet: Upregulated miR-4262 further decreases cell viability, autophagy, and matrix synthesis as well as increases apoptosis in TNF-α-treated chondrocytes. (A) The miR-4262 level in control, scramble (control of mimic), miR-4262 mimic, NC (control of inhibitor), and miR-4262 inhibitor groups by qPCR; (B) The cell viability in control, scramble, miR-4262 mimic, inhibitor NC, and miR-4262 inhibitor groups using CCK-8; (C) The cell apoptosis in control, scramble, miR-4262 mimic, inhibitor NC, and miR-4262 inhibitor groups using TUNEL staining; (D) The expression of autophagy-related proteins, including ULK1, ALG5, Beclin-1, LC3II/LC3I, in control, scramble, miR-4262 mimic, inhibitor NC, and miR-4262 inhibitor groups using western blotting; (E) The cell viability in control, TNF-α, TNF-α + scramble, TNF-α + miR-4262 mimic, TNF-α + NC, and TNF-α + miR-4262 inhibitor groups using CCK-8; (F) The cell apoptosis in control, TNF-α, TNF-α + scramble, TNF-α + miR-4262 mimic, TNF-α + NC, and TNF-α + miR-4262 inhibitor groups using TUNEL staining; (G) The expression of autophagy-related proteins, including ULK1, ALG5, Beclin-1, LC3II/LC3I, in control, TNF-α, TNF-α+E64d+pepstatin (A) TNF-α + scramble, TNF-α + miR-4262 mimic, TNF-α + NC, and TNF-α + miR-4262 inhibitor groups using western blotting; (H) The expression of matrix synthesis-related proteins, such as COL2A1, ACAN, MMP-13 and ADAMTS-5, in control, TNF-α, TNF-α + scramble, TNF-α + miR-4262 mimic, TNF-α + NC, and TNF-α + miR-4262 inhibitor groups using western blotting. Three independent experiments were performed in each assay. *P<0.05, **P<0.01, and ***P<0.001 TNF-α, tumor necrosis factor-α; ULK1, uncoordinated 51-like kinase 1; ALG5, asparagine-linked glycosylation 5; COL2A1, type II collagen; ACAN, aggrecan; MMP-13, matrix metallo protease 13; ADAMTS-5, a disintegrin and metalloproteinase with thrombospondin motifs-5.

Article Snippet: Total 50 µg protein sample (per lane) was separated on SDS-PAGE gel, blotted onto PVDF membranes, and blocked in 5% non-fat milk for 1 h. The membranes were probed with mouse polyclonal antibodies to ULK1 (120 kDa; 1;1,000; ab128859; Abcam, Cambridge, UK), ALG5 (32 kDa; 1;1,000; ab108327; Abcam), Beclin-1 (52 kDa; 1;1,000; ab62557; Abcam), LC3II/LC3I (LC3-II, 17 kDa, LC3-II 19 kDa; 1;1,000; ab48394; Abcam), COL2A1 (142 kDa; 1;1,000; ab34712; Abcam), ACAN (250 kDa; 1;1,000; ab36861; Abcam), MMP-13 (54 kDa; 1;1,000; ab39012; Abcam), ADAMTS-5 (73 kDa; 1;1,000; ab41037; Abcam), SIRT1 (120 kDa; 1;1,000; ab110304; Abcam), phospho-PI3K (p-PI3K) (84 kDa; 1;1,000; ab182651; Abcam), PI3K (123 kDa; 1;1,000; ab151549; Abcam), p-AKT (65 kDa; 1;1,000; SAB4301414; Sigma-Aldrich; Merck KGaA), AKT (55 kDa; 1;1,000; SAB4500797; Sigma-Aldrich; Merck KGaA), p-mTOR (250 kDa; 1;1,000; ab137133; Abcam), mTOR (252 kDa; 1;2,000; ab2732; Abcam), and GAPDH (36 kDa; 1;2,000; ab8245; Abcam) overnight at 4°C, respectively.

Techniques: CCK-8 Assay, TUNEL Assay, Staining, Expressing, Western Blot

Upregulated SIRT1 increases cell viability, autophagy, and matrix synthesis as well as decreases apoptosis in TNF-α-treated chondrocytes. (A) The SIRT1 level in control, pEX, pEX-SIRT1, siNC, and si-SIRT1 groups by qPCR; (B) The SIRT1 level in control, pEX, pEX-SIRT1, siNC, and si-SIRT1 groups by western blotting; The cell viability in (C) control, TNF-α, TNF-α + pEX, TNF-α + pEX-SIRT1, TNF-α + siNC, and TNF-α + si-SIRT1 groups using CCK-8; (D) The cell apoptosis in control, TNF-α, TNF-α + pEX, TNF-α + pEX-SIRT1, TNF-α + siNC, and TNF-α + si-SIRT1 groups using TUNEL staining; (E) The expression of autophagy-related proteins, including ULK1, ALG5, Beclin-1, LC3II/LC3I, in control, TNF-α, TNF-α + pEX, TNF-α + pEX-SIRT1, TNF-α + siNC, and TNF-α + si-SIRT1 groups using qPCR; (F) The expression of matrix synthesis-related proteins, such as COL2A1, ACAN, MMP-13 and ADAMTS-5, in control, TNF-α, TNF-α + pEX, TNF-α + pEX-SIRT1, TNF-α + siNC, and TNF-α + si-SIRT1 groups using qPCR. Three independent experiments were performed in each assay. *P<0.05, and **P<0.01 TNF-α, tumor necrosis factor-α; ULK1, uncoordinated 51-like kinase 1; ALG5, asparagine-linked glycosylation 5; COL2A1, type II collagen; ACAN, aggrecan; MMP-13, matrix metallo protease 13; ADAMTS-5, a disintegrin and metalloproteinase with thrombospondin motifs-5; SIRT1, sirtuin type 1.

Journal: Experimental and Therapeutic Medicine

Article Title: miR-4262 regulates chondrocyte viability, apoptosis, autophagy by targeting SIRT1 and activating PI3K/AKT/mTOR signaling pathway in rats with osteoarthritis

doi: 10.3892/etm.2017.5444

Figure Lengend Snippet: Upregulated SIRT1 increases cell viability, autophagy, and matrix synthesis as well as decreases apoptosis in TNF-α-treated chondrocytes. (A) The SIRT1 level in control, pEX, pEX-SIRT1, siNC, and si-SIRT1 groups by qPCR; (B) The SIRT1 level in control, pEX, pEX-SIRT1, siNC, and si-SIRT1 groups by western blotting; The cell viability in (C) control, TNF-α, TNF-α + pEX, TNF-α + pEX-SIRT1, TNF-α + siNC, and TNF-α + si-SIRT1 groups using CCK-8; (D) The cell apoptosis in control, TNF-α, TNF-α + pEX, TNF-α + pEX-SIRT1, TNF-α + siNC, and TNF-α + si-SIRT1 groups using TUNEL staining; (E) The expression of autophagy-related proteins, including ULK1, ALG5, Beclin-1, LC3II/LC3I, in control, TNF-α, TNF-α + pEX, TNF-α + pEX-SIRT1, TNF-α + siNC, and TNF-α + si-SIRT1 groups using qPCR; (F) The expression of matrix synthesis-related proteins, such as COL2A1, ACAN, MMP-13 and ADAMTS-5, in control, TNF-α, TNF-α + pEX, TNF-α + pEX-SIRT1, TNF-α + siNC, and TNF-α + si-SIRT1 groups using qPCR. Three independent experiments were performed in each assay. *P<0.05, and **P<0.01 TNF-α, tumor necrosis factor-α; ULK1, uncoordinated 51-like kinase 1; ALG5, asparagine-linked glycosylation 5; COL2A1, type II collagen; ACAN, aggrecan; MMP-13, matrix metallo protease 13; ADAMTS-5, a disintegrin and metalloproteinase with thrombospondin motifs-5; SIRT1, sirtuin type 1.

Article Snippet: Total 50 µg protein sample (per lane) was separated on SDS-PAGE gel, blotted onto PVDF membranes, and blocked in 5% non-fat milk for 1 h. The membranes were probed with mouse polyclonal antibodies to ULK1 (120 kDa; 1;1,000; ab128859; Abcam, Cambridge, UK), ALG5 (32 kDa; 1;1,000; ab108327; Abcam), Beclin-1 (52 kDa; 1;1,000; ab62557; Abcam), LC3II/LC3I (LC3-II, 17 kDa, LC3-II 19 kDa; 1;1,000; ab48394; Abcam), COL2A1 (142 kDa; 1;1,000; ab34712; Abcam), ACAN (250 kDa; 1;1,000; ab36861; Abcam), MMP-13 (54 kDa; 1;1,000; ab39012; Abcam), ADAMTS-5 (73 kDa; 1;1,000; ab41037; Abcam), SIRT1 (120 kDa; 1;1,000; ab110304; Abcam), phospho-PI3K (p-PI3K) (84 kDa; 1;1,000; ab182651; Abcam), PI3K (123 kDa; 1;1,000; ab151549; Abcam), p-AKT (65 kDa; 1;1,000; SAB4301414; Sigma-Aldrich; Merck KGaA), AKT (55 kDa; 1;1,000; SAB4500797; Sigma-Aldrich; Merck KGaA), p-mTOR (250 kDa; 1;1,000; ab137133; Abcam), mTOR (252 kDa; 1;2,000; ab2732; Abcam), and GAPDH (36 kDa; 1;2,000; ab8245; Abcam) overnight at 4°C, respectively.

Techniques: Western Blot, CCK-8 Assay, TUNEL Assay, Staining, Expressing

Effects of miR-4262 on cell viability, cell apoptosis, cell autophagy, and matrix synthesis is inhibited by SIRT1. (A) The cell viability in control, TNF-α, TNF-α + scramble + pEX, TNF-α + miR-4262 mimic, and TNF-α + miR-4262 mimic + pEX-SIRT1 groups using CCK-8; (B) The cell apoptosis in control, TNF-α, TNF-α + scramble + pEX, TNF-α + miR-4262 mimic, and TNF-α + miR-4262 mimic + pEX-SIRT1 groups using TUNEL staining; (C) The expression of autophagy-related proteins, including ULK1, ALG5, Beclin-1, LC3II/LC3I, in control, TNF-α, TNF-α + scramble + pEX, TNF-α + miR-4262 mimic, and TNF-α + miR-4262 mimic + pEX-SIRT1 groups using western blotting; (D) The expression of matrix synthesis-related proteins, such as COL2A1, ACAN, MMP-13 and ADAMTS-5, in control, TNF-α, TNF-α + scramble + pEX, TNF-α + miR-4262 mimic, and TNF-α + miR-4262 mimic + pEX-SIRT1 groups using western blotting. Three independent experiments were performed in each assay. *P<0.05, and **P<0.01 TNF-α, tumor necrosis factor-α; ULK1, uncoordinated 51-like kinase 1; ALG5, asparagine-linked glycosylation 5; COL2A1, type II collagen; ACAN, aggrecan; MMP-13, matrix metallo protease 13; ADAMTS-5, a disintegrin and metalloproteinase with thrombospondin motifs-5; SIRT1, sirtuin type 1.

Journal: Experimental and Therapeutic Medicine

Article Title: miR-4262 regulates chondrocyte viability, apoptosis, autophagy by targeting SIRT1 and activating PI3K/AKT/mTOR signaling pathway in rats with osteoarthritis

doi: 10.3892/etm.2017.5444

Figure Lengend Snippet: Effects of miR-4262 on cell viability, cell apoptosis, cell autophagy, and matrix synthesis is inhibited by SIRT1. (A) The cell viability in control, TNF-α, TNF-α + scramble + pEX, TNF-α + miR-4262 mimic, and TNF-α + miR-4262 mimic + pEX-SIRT1 groups using CCK-8; (B) The cell apoptosis in control, TNF-α, TNF-α + scramble + pEX, TNF-α + miR-4262 mimic, and TNF-α + miR-4262 mimic + pEX-SIRT1 groups using TUNEL staining; (C) The expression of autophagy-related proteins, including ULK1, ALG5, Beclin-1, LC3II/LC3I, in control, TNF-α, TNF-α + scramble + pEX, TNF-α + miR-4262 mimic, and TNF-α + miR-4262 mimic + pEX-SIRT1 groups using western blotting; (D) The expression of matrix synthesis-related proteins, such as COL2A1, ACAN, MMP-13 and ADAMTS-5, in control, TNF-α, TNF-α + scramble + pEX, TNF-α + miR-4262 mimic, and TNF-α + miR-4262 mimic + pEX-SIRT1 groups using western blotting. Three independent experiments were performed in each assay. *P<0.05, and **P<0.01 TNF-α, tumor necrosis factor-α; ULK1, uncoordinated 51-like kinase 1; ALG5, asparagine-linked glycosylation 5; COL2A1, type II collagen; ACAN, aggrecan; MMP-13, matrix metallo protease 13; ADAMTS-5, a disintegrin and metalloproteinase with thrombospondin motifs-5; SIRT1, sirtuin type 1.

Article Snippet: Total 50 µg protein sample (per lane) was separated on SDS-PAGE gel, blotted onto PVDF membranes, and blocked in 5% non-fat milk for 1 h. The membranes were probed with mouse polyclonal antibodies to ULK1 (120 kDa; 1;1,000; ab128859; Abcam, Cambridge, UK), ALG5 (32 kDa; 1;1,000; ab108327; Abcam), Beclin-1 (52 kDa; 1;1,000; ab62557; Abcam), LC3II/LC3I (LC3-II, 17 kDa, LC3-II 19 kDa; 1;1,000; ab48394; Abcam), COL2A1 (142 kDa; 1;1,000; ab34712; Abcam), ACAN (250 kDa; 1;1,000; ab36861; Abcam), MMP-13 (54 kDa; 1;1,000; ab39012; Abcam), ADAMTS-5 (73 kDa; 1;1,000; ab41037; Abcam), SIRT1 (120 kDa; 1;1,000; ab110304; Abcam), phospho-PI3K (p-PI3K) (84 kDa; 1;1,000; ab182651; Abcam), PI3K (123 kDa; 1;1,000; ab151549; Abcam), p-AKT (65 kDa; 1;1,000; SAB4301414; Sigma-Aldrich; Merck KGaA), AKT (55 kDa; 1;1,000; SAB4500797; Sigma-Aldrich; Merck KGaA), p-mTOR (250 kDa; 1;1,000; ab137133; Abcam), mTOR (252 kDa; 1;2,000; ab2732; Abcam), and GAPDH (36 kDa; 1;2,000; ab8245; Abcam) overnight at 4°C, respectively.

Techniques: CCK-8 Assay, TUNEL Assay, Staining, Expressing, Western Blot